Arthritis Resource Center CME

• 10.25 90.25
  Navigating the Joint Health Journey for Patients With Hemophilia: How Can You Make a Lasting Impact?
  Medscape Education Oncology September 06, 2022
  Do you know how to manage factor levels in patients with hemophilia with both replacement and nonreplacement factor products?
  
  0.25 CMEMIN 0.25 ABIM MOCMIN

  
  Save
• 10.25 90.25 20.25 30.25 80.25
  Which Moisturizer Makes a Difference in Childhood Eczema?
  Medscape Education Clinical Briefs September 02, 2022
  The efficacy of different forms of emollients is assessed in a new study.
  0.25 CME/CEMIN 0.25 ABIM MOCMIN 0.25 CEMIN 0.25 CEMIN 0.25 CEMIN

  
  Save
• 11.00 91.00
  Partnerships and Community Engagement Key to Policy, Systems, and Environmental Achievements for Healthy Eating and Active Living: A Systematic Mapping Review
  Preventing Chronic Disease August 25, 2022
  Early engagement with community leaders is key to success.
  1.00 CMEMIN 1.00 ABIM MOCMIN

  
  Save
• 10.50
  Rheumatoid Arthritis Management: Micro Lessons on Janus Kinase Inhibitors
  Medscape Education Rheumatology August 23, 2022
  Are you familiar with the latest safety and efficacy data for Janus kinase (JAK) inhibitors?
  
  0.50 CMEMIN

  
  Save
• 10.25 90.25
  JAK Inhibitors and Rheumatoid Arthritis: A Data Blitz
  Medscape Education Rheumatology August 18, 2022
  Are you up to date on the latest evidence regarding the use of JAK inhibitors in rheumatoid arthritis?
  
  0.25 CMEMIN 0.25 ABIM MOCMIN

  
  Save
• 10.50 90.50
  Conceptual Overview of Treatment Intensification in Hormone-Sensitive Prostate Cancer
  Medscape Education Oncology August 12, 2022
  What is treatment intensification for patients with hormone-sensitive prostate cancer (HSPC)?
  
  0.50 CMEMIN 0.50 ABIM MOCMIN

  
  Save
• 10.50 90.50 20.50
  Optimizing Outcomes in Patients With Metastatic Hormone-Sensitive Prostate Cancer
  Medscape Education Oncology July 26, 2022
  Do you know the data on androgen deprivation therapy, chemotherapy, and second-generation antiandrogens for hormone-sensitive prostate cancer (mHSPC)?
  
  0.50 CME/CEMIN 0.50 ABIM MOCMIN 0.50 CEMIN

  
  Save
• 10.50 90.50 20.50
  Driving Cessation vs Driver Retraining Among Older Adults
  Medscape Education Family Medicine June 29, 2022
  Do you address driving with your older patients? Find out how you can help improve their safety on the road.
  
  0.50 CME/CEMIN 0.50 ABIM MOCMIN 0.50 CEMIN

  
  Save
• 11.00 91.00
  Implementation of a Physical Activity Vital Sign in Primary Care: Associations Between Physical Activity, Demographic Characteristics, and Chronic Disease Burden
  Preventing Chronic Disease June 23, 2022
  Should primary care physicians use level of physical activity as a screening tool?
  
  1.00 CMEMIN 1.00 ABIM MOCMIN

  
  Save
• 11.00 91.00
  Natural History of and Dynamic Changes in Clinical Manifestation, Serology, and Treatment of Brucellosis, China
  Emerging Infectious Diseases June 21, 2022
  Diagnosing and managing human brucellosis can be challenging, are you up to date on the most current research?
  
  1.00 CMEMIN 1.00 ABIM MOCMIN

  
  Save
• 20.50
  A Genitourinary Overview of Bladder and Prostate Cancers
  Medscape Education Nurses June 20, 2022
  Our nurse expert summarizes the latest in bladder and prostate cancer management.
  
  0.50 CEMIN

  
  Save
• 10.25 90.25 20.25 30.25
  Current Evidence on the Use of Acetaminophen and NSAIDs for the Treatment of Osteoarthritis
  Medscape Education Cardiology June 16, 2022
  How to manage pain for patients with osteoarthritis? Drs Argoff and Hochberg discuss.
  
  0.25 CME/CEMIN 0.25 ABIM MOCMIN 0.25 CEMIN 0.25 CEMIN

  
  Save
• 10.50 90.50 20.50 30.50
  Relationship Between Osteoarthritis, Inflammation, and Pain: A Closer Examination
  Medscape Education Cardiology June 15, 2022
  Dr Sanchez Lopez provides an illustrative description of the pathological processes involved in osteoarthritis inflammation and pain.
  
  0.50 CME/CEMIN 0.50 ABIM MOCMIN 0.50 CEMIN 0.50 CEMIN

  
  Save
• 11.00 91.00 21.00 31.00
  Test Your Skill: Incorporating Biosimilars Into the Management of Patients With Immunological Conditions
  Medscape Education Oncology June 15, 2022
  Learn how to create a customized care plan for your patients that incorporates biosimilars.
  
  1.00 CME/CEMIN 1.00 ABIM MOCMIN 1.00 CEMIN 1.00 CEMIN

  
  Save
• 10.50 90.50
  Patient-Centric Case Discussion in Psoriatic Disease: Focus on Psoriatic Arthritis
  Medscape Education Rheumatology June 10, 2022
  Did you know that psoriatic arthritis affects about 30% of individuals with psoriasis?
  
  0.50 CMEMIN 0.50 ABIM MOCMIN

  
  Save
• 10.50 90.50
  Current State of Therapeutics in Spinal Muscular Atrophy: A Guide to Holistic Management
  Medscape Education Radiology May 13, 2022
  Join Dr Brandsema as he discusses current recommendations for optimizing care with approved medications indicated for the management of spinal muscular atrophy (SMA).
  
  0.50 CMEMIN 0.50 ABIM MOCMIN

  
  Save
• 10.50 90.50
  Understanding Underserved Populations in Transthyretin Amyloid Cardiomyopathy: A Guide to Effective Recognition and Management
  Medscape Education Cardiology April 07, 2022
  Amyloid cardiomyopathy: If you don’t think of it, you won’t diagnose it!
  
  0.50 CMEMIN 0.50 ABIM MOCMIN

  
  Save
• 10.50 90.50
  The Psoriasis to Psoriatic Arthritis Continuum: A Case-Based Discussion
  Medscape Education Rheumatology April 04, 2022
  An expert panel discusses strategies on how to optimize outcomes in patients with psoriasis.
  
  0.50 CMEMIN 0.50 ABIM MOCMIN

  
  Save
• 10.25 90.25 20.25 80.25
  What Affects Transition to Adulthood for Children With Juvenile Idiopathic Arthritis?
  Medscape Education Clinical Briefs April 01, 2022
  A long-term study of juvenile idiopathic arthritis showed inconsistent classification and management as children transition into adulthood.
  0.25 CME/CEMIN 0.25 ABIM MOCMIN 0.25 CEMIN 0.25 CEMIN

  
  Save
• Elevating Rheumatoid Arthritis Care: Advancements in JAK Inhibitor Therapy
  Medscape Education Rheumatology August 19, 2022
  Stay current on the latest in evidence-based recommendations for Janus kinase (JAK) inhibitors in the treatment rheumatoid arthritis.
  
  Save